BlackRock’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.21B | Sell |
22,050,045
-202,885
| -0.9% | -$8.3M | 0.02% | 660 |
|
|
2026
Q1 | $739M | Buy |
22,252,930
+404,468
| +2% | +$12.1M | 0.01% | 852 |
|
|
2025
Q4 | $651M | Buy |
21,848,462
+548,037
| +3% | +$17.9M | 0.01% | 930 |
|
|
2025
Q3 | $769M | Sell |
21,300,425
-512,881
| -2% | -$16.9M | 0.01% | 803 |
|
|
2025
Q2 | $785M | Buy |
21,813,306
+318,334
| +1% | +$11.9M | 0.01% | 759 |
|
|
2025
Q1 | $848M | Sell |
21,494,972
-403,786
| -2% | -$13.6M | 0.02% | 700 |
|
|
2024
Q4 | $659M | Sell |
21,898,758
-57,439
| -0.3% | -$1.65M | 0.01% | 897 |
|
|
2024
Q3 | $514M | Buy |
21,956,197
+10,567,851
| +93% | +$231M | 0.01% | 1052 |
|
|
2024
Q2 | $203M | Buy |
11,388,346
+544,844
| +5% | +$8.69M | ﹤0.01% | 1612 |
|
|
2024
Q1 | $165M | Buy |
10,843,502
+75,339
| +0.7% | +$1.2M | ﹤0.01% | 1770 |
|
|
2023
Q4 | $184M | Buy |
10,768,163
+781,216
| +8% | +$9.08M | ﹤0.01% | 1699 |
|
|
2023
Q3 | $83.5M | Buy |
9,986,947
+69,484
| +0.7% | +$969K | ﹤0.01% | 2096 |
|
|
2023
Q2 | $246M | Buy |
9,917,463
+1,067,763
| +12% | +$27.6M | 0.01% | 1440 |
|
|
2023
Q1 | $133M | Sell |
8,849,700
-284,247
| -3% | -$4.32M | ﹤0.01% | 1843 |
|
|
2022
Q4 | $108M | Buy |
9,133,947
+98,897
| +1% | +$718K | ﹤0.01% | 1935 |
|
|
2022
Q3 | $53.5M | Sell |
9,035,050
-227,275
| -2% | -$1.49M | ﹤0.01% | 2385 |
|
|
2022
Q2 | $39.4M | Buy |
9,262,325
+326,747
| +4% | +$2.04M | ﹤0.01% | 2646 |
|
|
2022
Q1 | $85M | Buy |
8,935,578
+33,413
| +0.4% | +$387K | ﹤0.01% | 2233 |
|
|
2021
Q4 | $169M | Buy |
8,902,165
+42,778
| +0.5% | +$1.11M | ﹤0.01% | 1865 |
|
|
2021
Q3 | $295M | Buy |
8,859,387
+507,028
| +6% | +$15.7M | 0.01% | 1423 |
|
|
2021
Q2 | $324M | Sell |
8,352,359
-947,240
| -10% | -$37.2M | 0.01% | 1413 |
|
|
2021
Q1 | $448M | Buy |
9,299,599
+743,313
| +9% | +$35.7M | 0.01% | 1095 |
|
|
2020
Q4 | $445M | Buy |
8,556,286
+871,567
| +11% | +$29.4M | 0.01% | 987 |
|
|
2020
Q3 | $206M | Buy |
7,684,719
+600,494
| +8% | +$13.8M | 0.01% | 1366 |
|
|
2020
Q2 | $138M | Buy |
7,084,225
+980,779
| +16% | +$15.8M | 0.01% | 1628 |
|
|
2020
Q1 | $60.1M | Buy |
6,103,446
+74,656
| +1% | +$943K | ﹤0.01% | 1949 |
|
|
2019
Q4 | $66.9M | Buy |
6,028,790
+420,835
| +8% | +$3.2M | ﹤0.01% | 2188 |
|
|
2019
Q3 | $31.5M | Buy |
5,607,955
+303,492
| +6% | +$2.12M | ﹤0.01% | 2554 |
|
|
2019
Q2 | $45.9M | Buy |
5,304,463
+866,572
| +20% | +$6.55M | ﹤0.01% | 2366 |
|
|
2019
Q1 | $35.7M | Sell |
4,437,891
-81,440
| -2% | -$440K | ﹤0.01% | 2467 |
|
|
2018
Q4 | $18.5M | Buy |
4,519,331
+98,479
| +2% | +$489K | ﹤0.01% | 2756 |
|
|
2018
Q3 | $24.8M | Buy |
4,420,852
+339,802
| +8% | +$3.88M | ﹤0.01% | 2747 |
|
|
2018
Q2 | $53.7M | Buy |
4,081,050
+605,844
| +17% | +$8.33M | ﹤0.01% | 2319 |
|
|
2018
Q1 | $49.3M | Buy |
3,475,206
+60,207
| +2% | +$769K | ﹤0.01% | 2275 |
|
|
2017
Q4 | $28M | Buy |
3,414,999
+115,252
| +3% | +$1.01M | ﹤0.01% | 2613 |
|
|
2017
Q3 | $39.1M | Buy |
3,299,747
+96,784
| +3% | +$1.1M | ﹤0.01% | 2433 |
|
|
2017
Q2 | $32.2M | Buy |
3,202,963
+530,455
| +20% | +$5.94M | ﹤0.01% | 2508 |
|
|
2017
Q1 | $31.1M | Buy |
2,672,508
+2,667,215
| +50,391% | +$19.1M | ﹤0.01% | 2491 |
|
|
2016
Q4 | $25K | Buy |
5,293
+1,604
| +43% | +$9.41K | ﹤0.01% | 3193 |
|
|
2016
Q3 | $28K | Sell |
3,689
-758
| -17% | -$4.88K | ﹤0.01% | 3205 |
|
|
2016
Q2 | $27K | Buy |
4,447
+1,041
| +31% | +$8.46K | ﹤0.01% | 3179 |
|
|
2016
Q1 | $29K | Buy |
3,406
+645
| +23% | +$5.64K | ﹤0.01% | 2657 |
|
|
2015
Q4 | $33K | Buy |
2,761
+2,180
| +375% | +$27.5K | ﹤0.01% | 2298 |
|
|
2015
Q3 | $6K | Hold |
581
| – | – | ﹤0.01% | 2952 |
|
|
2015
Q2 | $10K | Sell |
581
-114
| -16% | -$1.8K | ﹤0.01% | 2805 |
|
|
2015
Q1 | $11K | Buy |
695
+95
| +16% | +$1.44K | ﹤0.01% | 2691 |
|
|
2014
Q4 | $10K | Hold |
600
| – | – | ﹤0.01% | 2781 |
|
|
2014
Q3 | $6K | Hold |
600
| – | – | ﹤0.01% | 3013 |
|
|
2014
Q2 | $6K | Buy |
+600
| New | +$3.84K | ﹤0.01% | 3077 |
|
Other funds holding TGTX
SCM
CAM
BlackRock's TGTX Position: Q2 2026 in Review
BlackRock reduced its TG Therapeutics (TGTX) stake by 0.91% in Q2 2026, selling an estimated $8.3M and leaving 22,050,045 shares worth $1.21B. The position accounts for 0.02% of the portfolio, ranked #660.
BlackRock first reported a position in TGTX in Q2 2014 and has held it in 49 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- BlackRock held 22,050,045 shares of TG Therapeutics worth $1.21B as of Q2 2026.
- BlackRock sold 202,885 TG Therapeutics shares in Q2 2026, an estimated $8.3M.
- TG Therapeutics made up 0.02% of BlackRock's portfolio in Q2 2026, its #660 holding.
- BlackRock first reported a position in TG Therapeutics in Q2 2014 and has held it in 49 quarters since.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.